DESCRIPTION (provided by applicant): Hematopoietic stem cell transplantation (HSCT) has revolutionized the treatment of blood disorders, yet is severely limited by issues of donor/recipient immune incompatibility. Advances in stem cell biology hint at the means of circumventing these limitations through the generation of genetically matched tissues via somatic cell nuclear reprogramming. However, significant technical and ethical impediments must first be overcome. A 5-year career development plan is described wherein the principal investigator seeks to advance the understanding of nuclear reprogramming, while establishing an academic career in HSCT. The candidate will build on training in molecular genetics and clinical hematology/oncology to develop a command of developmental and stem cell biology under the mentorship of Dr. George Q. Daley. Dr. Daley is a leader in stem cell biology, with a comprehensive research program uniquely equipped to support the proposal. The plan is ideally conducted in the Division of Hematology at Children's Hospital, Boston, given the Division's distinguished record for training physician-scientists in a rich and collaborative research environment. The research is guided by the central hypothesis that careful analysis of normal mammalian embryonic development will reveal factors that can facilitate reprogramming in vitro. The studies focus on two poorly understood events in reprogramming: DMA demethylation and the establishment of pluripotency. Using a combination of molecular, genetic and developmental analyses, we aim to determine the roles of candidate factors implicated in normal embryogenesis and reprogramming.
The specific aims are to: 1) Determine if cytidine deaminases are essential for active DMA demethylation in the zygote, and whether they facilitate reprogramming during nuclear transfer, and (2) Determine if the transcription factor Nanog activates a pluripotency gene expression program during embryogenesis, and whether it can facilitate reprogramming after nuclear transfer.
The aims address questions of fundamental relevance in developmental biology, with potential significance for stem cell therapy. Additionally, execution of the aims will enable the principal investigator to develop the expertise necessary to establish a specialized scientific niche, from which an academic career in HSCT can be built.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Clinical Investigator Award (CIA) (K08)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-N (F1))
Program Officer
Welniak, Lisbeth A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Children's Hospital Boston
United States
Zip Code
Cherry, Anne B C; Gagne, Katelyn E; McLoughlin, Erin M et al. (2013) Induced pluripotent stem cells with a mitochondrial DNA deletion. Stem Cells 31:1287-97
Keller, Rachel B; Gagne, Katelyn E; Usmani, G Naheed et al. (2012) CTC1 Mutations in a patient with dyskeratosis congenita. Pediatr Blood Cancer 59:311-4
Agarwal, Suneet; Daley, George Q (2011) Telomere dynamics in dyskeratosis congenita: the long and the short of iPS. Cell Res 21:1157-60
Pessach, Itai M; Ordovas-Montanes, Jose; Zhang, Shen-Ying et al. (2011) Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. J Allergy Clin Immunol 127:1400-7.e4
Pastor, William A; Pape, Utz J; Huang, Yun et al. (2011) Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473:394-7
Gore, Athurva; Li, Zhe; Fung, Ho-Lim et al. (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471:63-7
MacMillan, Margaret L; Hughes, Mark R; Agarwal, Suneet et al. (2011) Cellular therapy for fanconi anemia: the past, present, and future. Biol Blood Marrow Transplant 17:S109-14
Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M et al. (2010) Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464:292-6
Bergmann, Anke K; Campagna, Dean R; McLoughlin, Erin M et al. (2010) Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations. Pediatr Blood Cancer 54:273-8
Tahiliani, Mamta; Koh, Kian Peng; Shen, Yinghua et al. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930-5